The effect of Quatrefolic® supplementation (400 µg/day plus vit B12 and B6) has been investigated in a retrospective study on pregnancy outcomes in infertile women undergoing ART, versus only folic acid.
Folate and vitamin B12, and the possible increased serum homocysteine (hyperhomocysteinemia, HHcy) – resulting by the shortage of these vitamins – are a very interesting investigation target for pre-conceptional health.
HHcy is believed to have important embryotoxic effects and adverse obstetric/neonatal outcomes.
Quatrefolic® and the higher chance of positive pregnancy outcomes
According to the new study just published by Cirillo et al. women undergoing Assisted Reproductive Treatments (ART) supplemented with vitamin B complex (5-methyltetrahydrofolate as Quatrefolic® plus vitamins B12 and B6 – Normocis® commercialized by the Italian company Inpha Duemila Srl) – have a higher chance of clinical pregnancy and live birth in comparison with those with only folic acid.
To know more about the study published, the people involved, the endpoints, and the findings reached, see the dedicated press release in the Quatrefolic® website.
DISCOVER ALL OUR LATEST NEWS
Vitamin K2: Debunking Myths and Understanding Benefits
Research consistently shows that while Vitamin K is crucial for normal blood coagulation, Vitamin K2 does not lead to excessive clotting or increased blood thickness. Today, we’re addressing the widespread myth that Vitamin K2 can cause elevated coagulation levels.
Adonat® Premium SAMe for Menopausal Women’s Well-Being
The S-adenosyl-L-methionine (SAMe) can be a versatile molecule in alleviating various symptoms associated with menopause, from hot flashes and mood changes to bone- and heart-health concerns.
Quatrefolic® Approved in China for Maternal Nutrition: A Breakthrough for Pregnant and Lactating Women
The registration approval of Quatrefolic® by Chinese authorities marks a significant milestone for its use in nutrient supplementary food for pregnant and lactating women.
